# Dean VandeKamp

> Dean VandeKamp is a Series B investor at Cultivation Capital backing Life Science and Therapeutics. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Cultivation Capital](https://shizune.co/investors/profile/cultivation-capital)
- Location: St Louis, United States
- Total investments: 1
- Last investment: Oct 2013
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/deanvandekamp/

Dean VandeKamp is a Series B investor at Cultivation Capital in St Louis focused on Life Science and Therapeutics. Dean VandeKamp - General Partner @ Cultivation Capital

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Life Science | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mobius Therapeutics | Mobius Therapeutics is an early-stage venture focused on ophthalmic surgery solutions. Its first product, Mitosol, is a system for delivering antifibrotic agents in glaucoma, refractive, and corneal surgery. It is awaiting regulatory approval, with additional product applications in earlier stages of development. | $5M | Series B | Oct 10, 2013 |  |

1 of 1 investments shown.

## About Cultivation Capital

VC Fund · St Louis, United States

Cultivation Capital is a venture capital firm that manages a family of funds focused on early-stage investing. Most of our initial investments are during a startup’s Seed or Series A phase, and our initial checks range from $500k – $3.5M. Our industries of focus include life sciences and health tech, software and IT, agriculture tech, andgeospatial tech.

5 contacts available at Cultivation Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Alana Mann | Principal | https://shizune.co/investors/profile/alana-mann |
| Andy Dearing | General Partner | https://shizune.co/investors/profile/andy-dearing |
| Brian Matthews | Co-Founder & General Partner | https://shizune.co/investors/profile/brian-matthews |
| David Smoller | General Partner - Life Sciences Fund | https://shizune.co/investors/profile/david-smoller |
| Dean VandeKamp | General Partner | https://shizune.co/investors/profile/dean-vandekamp |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Dean VandeKamp invest in?

Dean VandeKamp invests primarily in Life Science, Therapeutics and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dean VandeKamp last invest?

The most recent investment recorded for Dean VandeKamp closed in Oct 2013. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co